Related Experiment Videos
Antitumor effect of TNP-470 is not associated to decrease of angiogenesis in an experimental malignant
C Morales1, M Zurita, J Vaquero
1Neuroscience Research Unit of the Mapfre-Medicine Foundation, Puerta de Hierro Clinic, Autonomous University, Madrid, Spain.
Abstract:
The hypothesis that tumor growth depends on neovascularization has been broadly used in oncology research. TNP-470 is a fumagillin synthetic analog that is isolated from Aspergillus fumigatus, and experimental studies suggested that it shows antitumor effect mediated by its strong antiangiogenic effect. Because limited experience exists about the antitumoral effect of TNP-470 in cerebral tumors, we have carried out a study in order to evaluate the effect of TNP-470 on tumor growth and the vascular area in an experimental malignant neuroectodermic tumor growing in the subcutaneous space of immunocompetent Wistar rats. Our results showed a significant tumor growth inhibition in animals treated with TNP-470 when compared to those in the control group (intratumoral injections were administered in 30 mg/kg dose, three times a week on alternate days during four consecutive weeks). Since the quantitative analysis of tumor vascular parameters--number of microvessels and total intratumor vascular area--in the experimental groups did not show significant statistical differences, we conclude that TNP-470 has a significant antitumor effect on our neuroectodermic tumor, but this effect is mediated by other antineoplastic mechanisms that are independent of its previously described angiostatic capacity.
Insights
TNP-470 significantly inhibited neuroectodermic tumor growth in rats. However, this antitumor effect was not linked to its antiangiogenic properties, suggesting alternative mechanisms are at play.
Area of Science:
- Oncology
- Cancer Research
- Pharmacology
Background:
- Tumor growth is often linked to neovascularization.
- TNP-470, a synthetic analog of fumagillin, exhibits antiangiogenic and antitumor effects.
- Limited data exists on TNP-470's efficacy against cerebral tumors.
Purpose of the Study:
- To evaluate the antitumor effect of TNP-470 on malignant neuroectodermic tumors in rats.
- To assess the impact of TNP-470 on tumor vascularization.
Main Methods:
- An experimental model of malignant neuroectodermic tumor in Wistar rats was used.
- Rats received intratumoral injections of TNP-470 (30 mg/kg) three times weekly for four weeks.
- Tumor growth and vascular parameters (microvessel number, vascular area) were analyzed.
Main Results:
- TNP-470 treatment resulted in significant tumor growth inhibition compared to controls.
- No significant differences in microvessel count or total vascular area were observed between groups.
- Quantitative analysis of tumor vascular parameters did not show significant statistical differences.
Conclusions:
- TNP-470 demonstrates a significant antitumor effect on the studied neuroectodermic tumor.
- The antitumor activity of TNP-470 in this model is independent of its antiangiogenic capacity.
- Alternative antineoplastic mechanisms mediate TNP-470's efficacy against this tumor type.